STAT+: Novo’s subscription model raises questions about pharma-telehealth tie-ups

A delayed FDA decision for Orca Bio, new questions about pharma-telehealth tie-ups, and more
Source
Stat News
Opens original article in a new tab
AI Bias Analysis
4 models · Takes ~15 seconds

A delayed FDA decision for Orca Bio, new questions about pharma-telehealth tie-ups, and more
Source
Stat News
Opens original article in a new tab

(MedPage Today) -- "Why haven't they scheduled your dad for his feeding tube placement? They just want another family conference." I sighed and told my mother we may have to fight. The physicians caring for my father seemed ready to overrule her...

(MedPage Today) -- NEW ORLEANS -- For people with heart failure with preserved ejection fraction (HFpEF), monitoring for early fluid accumulation in the lungs allowed for earlier intervention and thus fewer heart failure (HF) hospitalizations...

Eli Lilly’s obesity pill was approved by the FDA, setting it up for fierce competition against Novo Nordisk’s new Wegovy pill.

(MedPage Today) -- Use of the antidepressant mirtazapine in routine clinical practice reduced methamphetamine use in adults with methamphetamine use disorder, a phase III randomized trial showed. In participants who used methamphetamine a median...